0002013833-24-000003.txt : 20240403
0002013833-24-000003.hdr.sgml : 20240403
20240403133250
ACCESSION NUMBER: 0002013833-24-000003
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
EFFECTIVENESS DATE: 20240403
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PreciseDx, Inc.
CENTRAL INDEX KEY: 0002013833
ORGANIZATION NAME:
IRS NUMBER: 841794606
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-509218
FILM NUMBER: 24817878
BUSINESS ADDRESS:
STREET 1: 111 AMSTERDAM AVENUE
STREET 2: STUYVESANT BUILDING 8-CO2
CITY: NEW YORK
STATE: NY
ZIP: 10025
BUSINESS PHONE: (646) 818-9330
MAIL ADDRESS:
STREET 1: 111 AMSTERDAM AVENUE
STREET 2: STUYVESANT BUILDING 8-CO2
CITY: NEW YORK
STATE: NY
ZIP: 10025
FORMER COMPANY:
FORMER CONFORMED NAME: PerciseDx, Inc.
DATE OF NAME CHANGE: 20240229
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0002013833
PreciseDx, Inc.
111 AMSTERDAM AVENUE
STUYVESANT BUILDING 8-CO2
NEW YORK
NY
NEW YORK
10025
(646) 818-9330
DELAWARE
PerciseDx, Inc.
Corporation
true
2020
Wayne
Brinster
111 Amsterdam Avenue
Stuyvesant Building 8-CO2
New York
NY
NEW YORK
10025
Executive Officer
Director
Chief Executive Officer and Director
Molly
Harper
111 Amsterdam Avenue
Stuyvesant Building 8-CO2
New York
NY
NEW YORK
10025
Director
Eric
Converse
111 Amsterdam Avenue
Stuyvesant Building 8-CO2
New York
NY
NEW YORK
10025
Director
Westley
Dupray
111 Amsterdam Avenue
Stuyvesant Building 8-CO2
New York
NY
NEW YORK
10025
Director
Erik
Lium
111 Amsterdam Avenue
Stuyvesant Building 8-CO2
New York
NY
NEW YORK
10025
Director
Other Health Care
Decline to Disclose
- 06b
true
0002013833-24-000001
2024-02-20
false
true
false
0
Aquilo Partners, L.P.
114909
None
None
601 California Street
5th Floor
San Francisco
CA
CALIFORNIA
94108
CA
CALIFORNIA
GA
GEORGIA
MA
MASSACHUSETTS
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
false
28220678
20720678
7500000
false
10
800000
0
0
false
PreciseDx, Inc.
/s/ Wayne Brinster
Wayne Brinster
Chief Executive Officer
2024-04-03